TRACON Pharmaceuticals Profit Margin

As of the most recent data (June 2024), TCON shows a profit margin of 162.34%. That compares with -343.28% in the prior-year period — up 147.3% year over year. That is above the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TCON's profit margin is now 162.34% (was -343.28%) — a 147.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether TRACON Pharmaceuticals is outperforming or lagging.

The Healthcare sector average profit margin is about 21.34%. TRACON Pharmaceuticals is at 162.34%, which is higher that average. That is roughly 660.9% above the sector mean. Use the comparison chart on this page to see how TCON stacks up against individual peers as well.

That compares with -343.28% in the prior-year period — up 147.3% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare TRACON Pharmaceuticals with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has TRACON Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 162.34%) with ownership activity and broader fundamentals.